InsiderClue
← All stocks

FILANA THERAPEUTICS, INC.

FLNA Net buying
CIK 0001069530 #4748 in the set updated 18 Sep 2026
Bought (12 mo)
$1.23M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.23M
+$1.23M against sales at will

By person

5 insiders · 9 transactions
4.0×

Richard J. Barry holds only 4.0 times base salary in stock. $2.72M of shares against $675.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard J. Barry last reported holding, valued at $2.90, the price Common Stock was last bought or sold at on the open market here, on 24 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Barry Richard
President & CEO
$1.17M (7)
—
+$1.17M
938,060
1.94%
$2.72M
+99.8%
Cook Robert Christopher
Chief Operating & Legal Office
$39.94K (1)
—
+$39.94K
13,725
0.0284%
$39.80K
—
Anderson Robert Eugene Jr
Director
$24.94K (1)
—
+$24.94K
8,600
0.0178%
$24.94K
—
Schoen Eric
Chief Financial Officer
—
—
—
11,500
0.0238%
$33.35K
−50.6%
Kupiec James William
Chief Medical Officer
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Anderson Robert Eugene Jr
24 Nov 2025
Director
Buy
8,600
$2.90
$24.94K
Barry Richard
20 Nov 2025
President & CEO
Buy indirect
150,000
$2.76
$414.00K
Barry Richard
19 Nov 2025
President & CEO
Buy indirect
73,385
$2.75
$201.81K
Cook Robert Christopher
30 Sep 2025
Chief Operating & Legal Office
Buy
13,725
$2.91
$39.94K
Barry Richard
22 Sep 2025
President & CEO
Buy indirect
7,172
$2.28
$16.35K
Barry Richard
19 Sep 2025
President & CEO
Buy indirect
46,908
$2.29
$107.42K
Barry Richard
19 Sep 2025
President & CEO
Buy indirect
400
$2.25
$900.00
Barry Richard
18 Sep 2025
President & CEO
Buy indirect
185,233
$2.24
$414.92K
Barry Richard
18 Sep 2025
President & CEO
Buy indirect
5,400
$2.13
$11.50K

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 5 May 2017